D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHRT
2826
AH Realty Trust
AHRT
$542M
| $1.22M | ﹤0.01% |
97,624
-10,061
| -9% | -$123K |
|
|
VNE
2827
PUT
DELISTED
Veoneer, Inc.
VNE
| $1.22M | ﹤0.01% |
+50,000
| New | +$1.31M |
|
2828
CALL
CRISPR Therapeutics
CRSP
$4.55B
| $1.22M | ﹤0.01% |
10,000
-10,000
| -50% | -$1.51M |
|
|
FRXB.U
2829
DELISTED
Forest Road Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-fifth of one redeemable warrant
FRXB.U
| $1.22M | ﹤0.01% |
+122,271
| New | +$1.23M |
|
2830
Arthur J. Gallagher & Co
AJG
$67.2B
| $1.21M | ﹤0.01% |
9,724
+6,813
| +234% | +$822K |
|
2831
Kite Realty
KRG
$5.99B
| $1.21M | ﹤0.01% |
+62,905
| New | +$1.14M |
|
2832
Global Payments
GPN
$23.6B
| $1.21M | ﹤0.01% |
6,009
+4,055
| +208% | +$808K |
|
2833
Enovix
ENVX
$849M
| $1.21M | ﹤0.01% |
+103,877
| New | +$1.36M |
|
|
ESTE
2834
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $1.21M | ﹤0.01% |
169,269
+154,510
| +1,047% | +$1.05M |
|
2835
Emcor
EME
$31B
| $1.21M | ﹤0.01% |
10,783
-41,427
| -79% | -$4.15M |
|
2836
Tyler Technologies
TYL
$13.7B
| $1.21M | ﹤0.01% |
2,849
-35,438
| -93% | -$15.3M |
|
2837
Franklin Covey
FC
$243M
| $1.21M | ﹤0.01% |
42,690
-31,019
| -42% | -$811K |
|
|
TBRG
2838
DELISTED
TruBridge
TBRG
| $1.21M | ﹤0.01% |
39,443
-51,669
| -57% | -$1.59M |
|
2839
Universal Electronics
UEIC
$57.8M
| $1.21M | ﹤0.01% |
21,931
-9,843
| -31% | -$568K |
|
2840
PUT
Cheniere Energy
LNG
$53B
| $1.2M | ﹤0.01% |
16,700
| – | – |
|
|
VTLE
2841
PUT
DELISTED
Vital Energy
VTLE
| $1.2M | ﹤0.01% |
+40,000
| New | +$1.23M |
|
2842
Katapult Holdings
KPLT
$32.4M
| $1.2M | ﹤0.01% |
3,668
-3,062
| -45% | -$1.18M |
|
2843
Simmons First National
SFNC
$3.36B
| $1.2M | ﹤0.01% |
+40,467
| New | +$1.14M |
|
2844
PUT
Veritone
VERI
$95.7M
| $1.2M | ﹤0.01% |
+50,100
| New | +$1.79M |
|
|
WRK
2845
DELISTED
WestRock Company
WRK
| $1.2M | ﹤0.01% |
+23,059
| New | +$1.08M |
|
|
FRONU
2846
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $1.2M | ﹤0.01% |
+120,578
| New | +$1.22M |
|
|
ADVWW
2847
DELISTED
Advantage Solutions Warrant
ADVWW
| $1.2M | ﹤0.01% |
372,446
-117,680
| -24% | -$262K |
|
2848
Jabil
JBL
$30.6B
| $1.19M | ﹤0.01% |
22,896
+16,117
| +238% | +$734K |
|
|
OPLN
2849
Openlane
OPLN
$4.27B
| $1.19M | ﹤0.01% |
79,582
-484,547
| -86% | -$8.25M |
|
2850
Banco Bradesco
BBD
$38.6B
| $1.19M | ﹤0.01% |
307,104
+27,715
| +10% | +$106K |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.